Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women

Blood Pressure

Volumn 19, Issue 3, 2010, Pages 156-163

  Brandin, Lisa M ^a   Gustafsson, Helena ^a   Ghanoum, Bachar ^a   Milsom, Ian ^b   Manhem, Karin ^a  

^a Institute of Medicine   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenergic reactivity; Blood pressure; Endothelium; Estrogen; Heart rate variability

Indexed keywords

ACETYLCHOLINE; AMILORIDE; ATENOLOL; CANDESARTAN; CAPTOPRIL; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ENALAPRIL; FELODIPINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN; METOPROLOL; NORADRENALIN; PLACEBO; SUBSTANCE P;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL BIOPSY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE RELAXATION; HEART RATE; HEART RATE VARIABILITY; HEMODYNAMICS; HUMAN; HUMAN TISSUE; HYPERTENSION; NERVE STIMULATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SUBCUTANEOUS FAT; SYMPATHETIC TONE; TREATMENT DURATION; VAGUS TONE;

ACETYLCHOLINE; ARTERIES; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION; MEDROXYPROGESTERONE; MIDDLE AGED; NOREPINEPHRINE; PROGESTERONE;

EID: 77952802161     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037050903435303     Document Type: Article

References (36)

1. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989;3:427-433.
2. Kannel WB. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA. 1996;275:1571-1576
3. Nelson HD, Humphrey HH, Nygren P, Teutsch SM, Allan JD. Postmenopausal replacement therapy: Scientific review. JAMA. 2002;288:872-881.
4. Amigoni S, Morelli P, Parazzini F, Chatenoud L. Determinants of elevated blood pressure in women around menopause: Results from a cross-sectional study in Italy. Maturitas. 2000;34:25-32.
5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
7. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613.
8. Mueck AO, Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas. 2004;49:189-203.
9. Manuck SB, Adams MR, McCaffery JM, Kaplan JR. Behaviorally elicited heart rate reactivity and atherosclerosis in ovariectomized cynomolgus monkeys (Macaca fascicularis). Arterioscler Thromb Vasc Biol. 1997;17:1774-1779.
10. Bedi M, Varshney VP, Babbar R. Role of cardiovascular reactivity to mental stress in predicting future hypertension. Clin Exp Hypertens. 2000;22:1-22.
11. Bairey Merz CN, Kop W, Krantz DS, Helmers KF, Berman DS, Rozanski A. Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women. Am Heart J. 1998;135:881-887.
12. Lindheim SR, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA, Presser SC, Lobo RA. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol. 1992;167:1831-1836.
13. He XR, Wang W, Crofton JT, Share L. Effects of 17betaestradiol on sympathetic activity and pressor response to phenylephrine in ovariectomized rats. Am J Physiol. 1998; 275:R1202-R1208.
14. Liu CC, Kuo TB, Yang CC. Effects of estrogen on genderrelated autonomic differences in humans. Am J Physiol Heart Circ Physiol. 2003;285:H2188-H2193.
15. Brandin L, Bergstrom G, Manhem K, Gustafsson H. Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat. J Hypertens. 2003;21:1695-1702.
16. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
17. Chen G, Cheung DW. Effect of K(+)-channel blockers on ACh-induced hyperpolarization and relaxation in mesenteric arteries. Am J Physiol. 1997;272:H2306-H2312.
18. Kuo TB, Linn T, Yang CC, Li CL, Chen CF, Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol. 1999;277:H2233-H2239.
19. Chang HR, Lee RP, Wu CY, Chen HI. Nitric oxide in mesenteric vascular reactivity: A comparison between rats with normotension and hypertension. Clin Exp Pharmacol Physiol. 2002;29:275-280.
20. Sudhir K, Elser MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension. 1997;30:1538-1543.
21. Ford SP, Reynolds LP, Farley DB, Bhatnagar RK, Van Orden DE. Interaction of ovarian steroids and periarterial alpha 1-adrenergic receptors in altering uterine blood flow during the estrous cycle of gilts. Am J Obstet Gynecol. 1984;150: 480-484.
22. Ferrer M, Meyer M, Osol G. Estrogen replacement increases beta-adrenoceptor-mediated relaxation of rat mesenteric arteries. J Vasc Res. 1996;33:124-133.
23. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, Ohama K, Chayama K, Oshima T. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension. 2001;37:651-657.
24. Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol. 1999;126:709-716.
25. Lima SM, Aldrighi JM, Consolim-Colombo FM, Mansur Ade P, Rubira MC, Krieger EM, et al. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women. Maturitas. 2005;50:266-274.
26. Kublickiene K, Svedas E, Landgren BM, Crisby M, Nahar N, Nisell H, Poston L. Small artery endothelial dysfunction in postmenopausal women: In vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators. J Clin Endocrinol Metab. 2005;90:6113-6122.
27. Manhem K, Brandin L, Ghanoum B, Rosengren A, Gustafsson H. Acute effects of transdermal estrogen on hemodynamic and vascular reactivity in elderly postmenopausal healthy women. J Hypertens. 2003;21:387-394.
28. Nawate S, Fukao M, Sakuma I, Soma T, Nagai K, Takikawa O, et al. Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol. 2005;144:178-189.
29. Cheng DY, Feng CJ, Kadowitz PJ, Gruetter CA. Effects of 17 beta-estradiol on endothelium-dependent relaxation induced by acetylcholine in female rat aorta. Life Sci. 1994;55:PL187-PL191.
30. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17 betaestradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988;244:19-22.
31. Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause. 2007;14:408-414.
32. White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17?-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation. 2005;112:1979-1983.
33. Janszky I, Ericson M, Mittleman MA, Wamala S, Al-Khalili S, Schenk-Gustafsson K, et al. Heart rate variability in longterm risk assessment in middle-aged women with coronary heart disease: The Stockholm Female Coronary Risk Study. J Intern Med. 2004;255:13-21.
34. Niskanen L, Laitinen T, Tuppurainen M, Saarikoski S, Kroger H, Alhava E, et al. Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? Menopause. 2002;9:52-57.
35. Rosa Brito-Zurita O, Posadas-Romero C, Hermosillo AG, Zamora-Gonzalez J, Hernandez-Ono A, Cardoso-Saldana G, et al. Estrogen effect on heart rate variability in hypertensive postmenopausal women. Maturitas. 2003;44:39-48.
36. Girdler SS, Hinderliter AL, Wells EC, Sherwood A, Grewen KM, Light KC. Transdermal versus oral estrogen therapy in postmenopausal smokers: Hemodynamic and endothelial effects. Obstet Gynecol. 2004;103:169-180.